Surveillance and Health Equity Science, American Cancer Society, 3380 Chastain Meadows Pkwy NW Suite 200, Kennesaw, GA, 30144, USA.
Isr J Health Policy Res. 2023 Jul 6;12(1):24. doi: 10.1186/s13584-023-00572-x.
Cancer is one of the most expensive medical conditions to treat worldwide, affecting national and local spending, as well as household budgets for patients and their families. In this commentary about a recent paper from Tur‑Sinai et al., we discuss the high out-of-pocket spending and medical and non-medical financial hardship faced by cancer patients and their families at the end-of-life in Israel. We provide recent information about the costs of health care in Israel and other high-income countries with (i.e., Canada, Australia, Japan, and Italy) and without universal health insurance coverage (i.e., United States, a country with high healthcare costs and uninsurance rate), and highlight the role of improving health insurance coverage and benefit design in reducing financial hardship among cancer patients and their families. Recognizing that financial hardship at the end of life affects both patients and their families, developing comprehensive programs and policies in Israel as well as in other countries is warranted.
癌症是全球治疗费用最昂贵的疾病之一,影响国家和地方的支出,以及患者及其家庭的家庭预算。在这篇关于 Tur-Sinai 等人最近一篇论文的评论中,我们讨论了以色列癌症患者及其家庭在生命末期面临的高昂自付费用以及医疗和非医疗经济困难。我们提供了有关以色列和其他高收入国家(即加拿大、澳大利亚、日本和意大利)和没有全民医疗保险的国家(即美国,一个医疗费用高、无保险率的国家)的医疗保健费用的最新信息,并强调了改善医疗保险覆盖范围和福利设计在减轻癌症患者及其家庭经济困难方面的作用。认识到生命末期的经济困难既影响患者又影响其家庭,因此有必要在以色列和其他国家制定综合方案和政策。